The mechanisms of ILD are unknown, and someone may even consider ILD with CDK4/6 inhibitors a paradoxical event since the anti-proliferative mode of action of these agents can be theoretically useful in counteracting lung fibrosis. The gene discussed is CDK4; the disease is interstitial lung disease.